Starpharma Holdings Ltd (SPL) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.182x

Based on the latest financial reports, Starpharma Holdings Ltd (SPL) has a cash flow conversion efficiency ratio of 0.182x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$3.91 Million ≈ $2.77 Million USD) by net assets (AU$21.48 Million ≈ $15.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Starpharma Holdings Ltd (SPL) net asset quality to measure how much of total assets are equity-financed.

Starpharma Holdings Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Starpharma Holdings Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SPL operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Starpharma Holdings Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Starpharma Holdings Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Metro Mining Limited
F:6ME
-0.025x
Claros Mortgage Trust Inc
NYSE:CMTG
0.005x
First Savings Financial Group Inc
NASDAQ:FSFG
0.544x
Sindoh
KO:029530
0.023x
Ritek Corp
TW:2349
-0.009x
Backblaze Inc
NASDAQ:BLZE
0.069x
Senao Networks
TWO:3558
0.049x
Magnora ASA
OL:MGN
-0.119x

Annual Cash Flow Conversion Efficiency for Starpharma Holdings Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Starpharma Holdings Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Starpharma Holdings Ltd (SPL) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$19.00 Million
≈ $13.44 Million
AU$-6.76 Million
≈ $-4.78 Million
-0.356x -43.37%
2024-06-30 AU$28.12 Million
≈ $19.89 Million
AU$-6.98 Million
≈ $-4.94 Million
-0.248x +36.16%
2023-06-30 AU$34.81 Million
≈ $24.63 Million
AU$-13.53 Million
≈ $-9.58 Million
-0.389x -42.92%
2022-06-30 AU$48.39 Million
≈ $34.24 Million
AU$-13.16 Million
≈ $-9.31 Million
-0.272x -14.43%
2021-06-30 AU$62.30 Million
≈ $44.08 Million
AU$-14.81 Million
≈ $-10.48 Million
-0.238x +30.90%
2020-06-30 AU$31.33 Million
≈ $22.17 Million
AU$-10.78 Million
≈ $-7.62 Million
-0.344x -40.99%
2019-06-30 AU$42.40 Million
≈ $30.00 Million
AU$-10.34 Million
≈ $-7.32 Million
-0.244x -27.43%
2018-06-30 AU$53.28 Million
≈ $37.70 Million
AU$-10.20 Million
≈ $-7.22 Million
-0.191x +31.13%
2017-06-30 AU$60.98 Million
≈ $43.15 Million
AU$-16.95 Million
≈ $-12.00 Million
-0.278x +22.85%
2016-06-30 AU$49.42 Million
≈ $34.97 Million
AU$-17.81 Million
≈ $-12.60 Million
-0.360x +0.59%
2015-06-30 AU$37.56 Million
≈ $26.57 Million
AU$-13.62 Million
≈ $-9.63 Million
-0.363x -21.73%
2014-06-30 AU$32.95 Million
≈ $23.31 Million
AU$-9.81 Million
≈ $-6.94 Million
-0.298x -39.76%
2013-06-30 AU$45.97 Million
≈ $32.53 Million
AU$-9.79 Million
≈ $-6.93 Million
-0.213x -6.11%
2012-06-30 AU$48.65 Million
≈ $34.42 Million
AU$-9.77 Million
≈ $-6.91 Million
-0.201x +14.13%
2011-06-30 AU$27.69 Million
≈ $19.59 Million
AU$-6.48 Million
≈ $-4.58 Million
-0.234x -124.47%
2010-06-30 AU$34.84 Million
≈ $24.65 Million
AU$-3.63 Million
≈ $-2.57 Million
-0.104x +34.07%
2009-06-30 AU$25.50 Million
≈ $18.04 Million
AU$-4.03 Million
≈ $-2.85 Million
-0.158x +39.82%
2008-06-30 AU$20.38 Million
≈ $14.42 Million
AU$-5.35 Million
≈ $-3.79 Million
-0.263x -99.82%
2007-06-30 AU$25.72 Million
≈ $18.20 Million
AU$-3.38 Million
≈ $-2.39 Million
-0.131x +62.60%
2006-06-30 AU$21.32 Million
≈ $15.08 Million
AU$-7.49 Million
≈ $-5.30 Million
-0.351x +39.71%
2005-06-30 AU$9.97 Million
≈ $7.05 Million
AU$-5.81 Million
≈ $-4.11 Million
-0.583x -76.57%
2004-06-30 AU$17.59 Million
≈ $12.45 Million
AU$-5.81 Million
≈ $-4.11 Million
-0.330x +22.04%
2002-06-30 AU$17.27 Million
≈ $12.22 Million
AU$-7.31 Million
≈ $-5.17 Million
-0.423x -329.93%
2001-06-30 AU$24.92 Million
≈ $17.63 Million
AU$-2.45 Million
≈ $-1.74 Million
-0.098x --

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology
Market Cap
$238.27 Million
AU$336.74 Million AUD
Market Cap Rank
#15880 Global
#434 in Australia
Share Price
AU$0.80
Change (1 day)
+6.67%
52-Week Range
AU$0.10 - AU$0.80
All Time High
AU$2.49
About

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurr… Read more